Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Merck gets another Phase 3 win for sac-TMT, this time in gastric cancer

An experimental antibody-drug conjugate from Merck has succeeded in another Phase 3 cancer study, potentially helping offset Keytruda's looming patent cliff. Merck said Friday morning that a pivotal trial testing sacituzumab ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

Measles in America: Here's a constructive approach to beating the highly contagious disease, based on Brazil's experience

The US is now officially a measles contagion zone. By mid-2026, there were more infections than in all of the previous year. But it could beat measles again, just like Brazil did two years ago.

  • United States lost measles-free status in 2026, similar to Brazil's 2019 situation
  • US saw over 5,400 measles cases in 2026, mostly among unvaccinated/under-vaccinated individuals

More from Friday 20 November →